Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia

about

Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy

P2860

Q58544569-DC4A782D-A0F7-4A85-B9A5-D1308B42351E

P2860

Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia

Item

http://www.wikidata.org/entity/Q36816685

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia

@ast

Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia

@en

type

Item

label

Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia

@ast

Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia

@en

prefLabel

Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia

@ast

Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia

@en

P1476

Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia

@en

P2093

Federico De Angelis

http://www.w3.org/2001/XMLSchema#string

P2860

Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia

A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group

Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups

Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia

The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion

Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia.

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data.

P304

119-132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S40487-015-0013-8

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Massimo Breccia

P577

2015-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284029259

http://www.w3.org/2001/XMLSchema#string

P698

27182481

http://www.w3.org/2001/XMLSchema#string

P932

4837932

http://www.w3.org/2001/XMLSchema#string

Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia

about

P2860

P2860

Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932